www.bethelfinance.com
Bethel Finance news:
Perrigo Company (Nasdaq:PRGO; TASE:PRGO) has acquired the assets of CamAm Care, a diabetes care products distributor for $36 million. The assets include : Dex4 hypoglycemia tabs, liquids and gels, insulin delivery syringes and pen needles, lancing, wound care, and compression stockings.
"Perrigo said that these store brand products will compete in the $1.5 billion annual US diabetes healthcare markets" said Mr. Peres Sailam (Bethel Finance Ltd).
Perrigo chairman and CEO Joseph Papa said, "This acquisition, alongside the store brand glucose monitoring meters and strips powered by ONsync launched in 2011 with AgaMatrix, showcases our continued commitment to providing a comprehensive line of quality, affordable healthcare to the growing diabetes community."
Perrigo's share price rose 0.4% in early trading on Nasdaq today to $96.42, giving a market cap of $9 billion, after rising 0.6% on the TASE to NIS 307.50.
No comments:
Post a Comment